Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma: Phase 3 CALGB 80802 Randomized Clinical Trial
索拉非尼联合多柔比星与索拉非尼单药治疗晚期肝细胞癌患者的疗效评估:CALGB 80802 III期随机临床试验
期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2019.2792
Abou-Alfa, Ghassan K; Shi, Qian; Knox, Jennifer J; Kaubisch, Andreas; Niedzwiecki, Donna; Posey, James; Tan, Benjamin R Jr; Kavan, Petr; Goel, Rakesh; Lammers, Philip E; Bekaii-Saab, Tanios S; Tam, Vincent C; Rajdev, Lakshmi; Kelley, Robin K; El Dika, Imane; Zemla, Tyler; Potaracke, Ryan I; Balletti, Jennifer; El-Khoueiry, Anthony B; Harding, James J; Suga, Jennifer M; Schwartz, Lawrence H; Goldberg, Richard M; Bertagnolli, Monica M; Meyerhardt, Jeffrey; O'Reilly, Eileen M; Venook, Alan P